CompanyPrivateOsaka, Japan

Mitsubishi Tanabe Pharma

ClinicalTrials.gov

10-QNov 9Latest SEC filing

Nov 9Latest story

November 2026

ADC Therapeutics reports Q3 2026 results, restructuring extends cash runway into 2029

Nov 9Quarterly updateADC Therapeutics SA loncastuximab tesirine